Ireland
--:--IST
Starting soon Not applicable

Laughter Yoga- Integrated Virtual Reality Nature Exploration in Early Stage of Chemotherapy

NCT07798661 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-09-15
Last updated
2026-09-01

Condition(s) studied

Patiens in Early Stage of Chemotherapy

Investigational drug(s) / intervention(s)

laughter yoga-integrated virtual reality

laughter yoga-integrated virtual reality: A digital-based behavioral approach for symptom control

Study summary

After obtaining informed consent, pre-test applications will be performed on participants in the experimental and control groups following randomization, and information regarding treatment plans will be recorded. Patients in the experimental group will receive laughter yoga practice integrated with virtual reality videos during chemotherapy infusion. The practice is planned to be once a week for four weeks. High-resolution, adjustable virtual reality glasses with head and hand tracking features will be used for the virtual reality application. The videos will consist of relaxing content such as nature walks, beach and sea views, and will be prepared in three-dimensional, 360-degree viewing angles integrated with laughter yoga exercises. Personalized video content will be created according to the participants' preferences, and the viewing time will be limited to 10 minutes for each application. After the completion of the fourth course, data collection tools will be re-administered for post-testing purposes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: ≥18 years of age, being in the early stage of chemotherapy, no surgical treatment plan, voluntary participation. Exclusion Criteria: psychiatric disorder, treatments other than chemotherapy, not in the early stage of chemotherapy vision and hearing problems, planned surgical procedure, skin/eye infections that would prevent the use of virtual reality, previous laughter yoga experience.

Primary outcome measure(s)

  • Pittsburgh Sleep Quality Index — 4 week
    This self-report scale, used to assess sleep quality and sleep-related problems, consists of seven components. The scale was first developed by Buysse et al. in 1989, and studies have shown that it has sufficient internal consistency (Cronbach's alpha=0.80), test-retest reliability, and construct validity. The Turkish validity and reliability study of the scale was carried out by Ağargün et al., and it was shown that it can be used in the Turkish population.
  • State-Trait Anxiety Inventory (STAI) — 4 week
    Developed by Spielberger et al. and adapted into Turkish by Öner and Le Compte, this inventory assesses anxiety levels. It includes two subscales, each consisting of 20 items, measuring the individual's immediate anxiety level and general anxiety tendency separately. The scale is evaluated on a four-point Likert scale, with scores ranging from 20 to 80, indicating a higher level of anxiety.

Trial sites (1)

FacilityCityRegionStatus
Atatürk University Faculty of Nursing Erzurum YAKUTİYE
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07798661 on ClinicalTrials.gov ↗ ← All trials in Turkey